Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
about
Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Clinically relevant concentrat ...... CFU-GM to adriamycin and VP16.
@en
Clinically relevant concentrat ...... CFU-GM to adriamycin and VP16.
@nl
type
label
Clinically relevant concentrat ...... CFU-GM to adriamycin and VP16.
@en
Clinically relevant concentrat ...... CFU-GM to adriamycin and VP16.
@nl
prefLabel
Clinically relevant concentrat ...... CFU-GM to adriamycin and VP16.
@en
Clinically relevant concentrat ...... CFU-GM to adriamycin and VP16.
@nl
P2093
P2860
P356
P1476
Clinically relevant concentrat ...... CFU-GM to adriamycin and VP16.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1988.131
P407
P577
1988-06-01T00:00:00Z